Synchronous Bilateral Talc Pleurodesis

Synchronous Bilateral Talc Pleurodesis for Malignant Bilateral Pleural Effusions

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07810049

Enrollment

Registered

2026-09-09

Start date

1998-01-01

Completion date

2025-09-30

Last updated

2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bilateral Pleural Effusion, Pleurodesis

Keywords

lung cancer, malignant pleural effusion, pleurodesis, bilateral pleural effusion

Brief summary

Investigate feasibility of synchronous bilateral talc pleurodesis for malignant bilateral pleural effusions

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥ 18 year-old * Patients undergoing synchronous bilateral talc pleurodesis * Diagnosis of malignant bilateral pleural effusions * Surgical resection between 1998 and September 2025

Exclusion criteria

* Other type of surgery * Lack of consent to research * Other type of diagnosis (e.g. viral disease)

Design outcomes

Primary

Measure	Time frame	Description
postoperative mortality	35 years	Evaluation of postoperative complications occurred after talc pleurodesis.
postoperative morbidity	35 years	Evaluation of postoperative complications occurred after talc pleurodesis.

Countries

Italy

Outcome results